BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 23768509)

  • 21. Nanoparticles for tumor targeted therapies and their pharmacokinetics.
    Wang J; Sui M; Fan W
    Curr Drug Metab; 2010 Feb; 11(2):129-41. PubMed ID: 20359289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells.
    Su J; Chen F; Cryns VL; Messersmith PB
    J Am Chem Soc; 2011 Aug; 133(31):11850-3. PubMed ID: 21751810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
    Ge Z; Liu S
    Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actively targeted nanocarriers for drug delivery to cancer cells.
    Biffi S; Voltan R; Bortot B; Zauli G; Secchiero P
    Expert Opin Drug Deliv; 2019 May; 16(5):481-496. PubMed ID: 30955393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual nanoparticle drug delivery: the future of anticancer therapies?
    King MR; Mohamed ZJ
    Nanomedicine (Lond); 2017 Jan; 12(2):95-98. PubMed ID: 27885896
    [No Abstract]   [Full Text] [Related]  

  • 28. Polymer-Drug Conjugates for Anticancer Drug Delivery.
    Wadhwa S; Mumper RJ
    Crit Rev Ther Drug Carrier Syst; 2015; 32(3):215-45. PubMed ID: 26080809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecularly imprinted polymer essentials: curation of anticancer, ophthalmic, and projected gene therapy drug delivery systems.
    Tuwahatu CA; Yeung CC; Lam YW; Roy VAL
    J Control Release; 2018 Oct; 287():24-34. PubMed ID: 30110614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microfluidics: a focus on improved cancer targeted drug delivery systems.
    Khan IU; Serra CA; Anton N; Vandamme T
    J Control Release; 2013 Dec; 172(3):1065-74. PubMed ID: 23933524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
    Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
    J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy.
    Sun L; Wu Q; Peng F; Liu L; Gong C
    Colloids Surf B Biointerfaces; 2015 Nov; 135():56-72. PubMed ID: 26241917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance.
    Khot VM; Salunkhe AB; Pricl S; Bauer J; Thorat ND; Townley H
    Drug Discov Today; 2021 Mar; 26(3):724-739. PubMed ID: 33359624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymer nanoparticulate drug delivery and combination cancer therapy.
    Cao P; Bae Y
    Future Oncol; 2012 Nov; 8(11):1471-80. PubMed ID: 23148619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications.
    Sabra S; Abdelmoneem M; Abdelwakil M; Mabrouk MT; Anwar D; Mohamed R; Khattab S; Bekhit A; Elkhodairy K; Freag M; Elzoghby A
    Curr Pharm Des; 2017; 23(35):5213-5229. PubMed ID: 28552068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temperature-responsive polymeric micelles for optimizing drug targeting to solid tumors.
    Akimoto J; Nakayama M; Okano T
    J Control Release; 2014 Nov; 193():2-8. PubMed ID: 25037017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymeric Engineering of Aptamer-Drug Conjugates for Targeted Cancer Therapy.
    Deng Z; Yang Q; Peng Y; He J; Xu S; Wang D; Peng T; Wang R; Wang XQ; Tan W
    Bioconjug Chem; 2020 Jan; 31(1):37-42. PubMed ID: 31815437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular insights and novel approaches for targeting tumor metastasis.
    Das SS; Alkahtani S; Bharadwaj P; Ansari MT; ALKahtani MDF; Pang Z; Hasnain MS; Nayak AK; Aminabhavi TM
    Int J Pharm; 2020 Jul; 585():119556. PubMed ID: 32574684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymersomes and their applications in cancer delivery and therapy.
    Guan L; Rizzello L; Battaglia G
    Nanomedicine (Lond); 2015; 10(17):2757-80. PubMed ID: 26328898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor-Acceptor-Type Conjugated Polymer-Based Multicolored Drug Carriers with Tunable Aggregation-Induced Emission Behavior for Self-Illuminating Cancer Therapy.
    Wang Z; Wang C; Gan Q; Cao Y; Yuan H; Hua D
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):41853-41861. PubMed ID: 31668068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.